Continued sustained release of VEGF by PLGA nanospheres modified BAMG stent for the anterior urethral reconstruction of rabbit

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 6, 2013, Pages 481-484

  Wang, Ji Hong ^a   Xu, Yue Min ^a   Fu, Qiang ^a   Song, Lu Jie ^a   Li, Chao ^a   Zhang, Qin ^a   Xie, Ming Kai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bladder acellular matrix graft; PLGA nanospheres; Vascular endothelial growth factor

Indexed keywords

ACTIN; CD31 ANTIGEN; CD34 ANTIGEN; NANOSPHERE; POLYLACTIC ACID GLYCOLIC ACID NANOSPHERE; PROTEIN A SAM; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLADDER ACELLULAR MATRIX GRAFT STENT; BLOOD VESSEL PARAMETERS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MICROVASCULAR TAG COUNT; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; RESTENOSIS; SCAR FORMATION; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING; URETHRA RESTENOSIS; URETHRA STENOSIS; URETHRA STRICTURE; URETHRAL STENT; URETHROGRAPHY; URETHROPLASTY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD31; ANTIGENS, CD34; DELAYED-ACTION PREPARATIONS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LACTIC ACID; MALE; MATERIALS TESTING; NANOSPHERES; POLYGLYCOLIC ACID; RABBITS; RECONSTRUCTIVE SURGICAL PROCEDURES; STENTS; TISSUE SCAFFOLDS; URETHRA; URINARY BLADDER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892383338     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60078-4     Document Type: Article

References (10)

1. Han P, Song C, Yang YR, Wang KJ, Wei Q, Li H Construction of tissue-engineered urothelial tissue in vitro and in vivo with bladder acellular matrix as scaffold. J Central South Univ (Medical Edition) 2007, 32(6):1058-1063.
2. Liu J, Xu WH, Jin C The study of the preparation and properties of loaded adriamycin PLGA nanoparticles mic rospheres. Modern Biomed Progr 2010, 24(10):4661-4663.
3. Bolland F, Korossis S, Wilshaw SP, Ingham E, Fisher J, Kearney JN, et al. Development and characterisation of a full-thickness acellular porcine bladder matrix for tissue engineering. Biomaterials 2007, 28(6):1061-1070.
4. Brunt KR, Hall SR, Ward CA, Melo LG Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction. Methods Mol Med 2007, 139:197-210.
5. Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J, et al. Comparative evaluation of long-term clinical efficacy with catheter-based percutaneous intramyocardial autologous bone marrow cell implantation versus laser myocardial revascularization in patients with severe coronary artery disease. Am Heart J 2007, 154(5):982.e1-6.
6. Fadini GP, Schiavon M, Avogaro A, Agostini C The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2007, 24(2):85-93.
7. Hemalatha J, Wilma DSCR Evaluation of effect of smoking and hypertension on serum lipid profile and oxidative stress. Asian Pac J Trop Biomed 2011, 1(4):289-291.
8. Sakr S, Rashed L, Zarouk W, El-Shamy R Effect of mesenchymal stem cells on anti-Thy1,1 induced kidney injury in albino rats. Asian Pac J Trop Biomed 2013, 3(3):174-181.
9. Ohgushi H, Morishita T, Dohi Y, Tadokoro M, Tanaka Y, Takakura Y, et al. Bone marrow-derived mesenchymal cells can rescue osteogenic capacity of devitalized autologous bone. J Tissue Eng Regen Med 2008, 2(1):61-68.
10. Kienstra KA, Jackson KA, Hirschi KK Injury mechanism dictates contribution of bone marrow-derived cells to murine hepatic vascular regeneration. Pediatr Res 2008, 63(2):131-136.